NEW YORK (GenomeWeb News) – Accelrys said after the close of the market on Tuesday that its first-quarter revenues were up 7 percent year over year.

Total revenues for the three months ended March 31 were $42.1 million, compared to $39.4 million for the first quarter a year ago, short of the average Wall Street estimate of $45.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.